Helena B Pasieka
Overview
Explore the profile of Helena B Pasieka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
194
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Needham M, Pichardo R, Alavi A, Chang A, Daveluy S, DeNiro K, et al.
Cutis
. 2024 Jul;
113(6):251-254.
PMID: 39082985
Inpatient hospitalization of individuals with hidradenitis suppurativa (HS) has increased. Inpatient services may not be familiar enough with this disease to understand how to manage severe HS and/or HS flares....
2.
Biro M, Hill A, Cardis M, Pasieka H, Farhat F
JAAD Case Rep
. 2023 Nov;
42:42-44.
PMID: 38034365
No abstract available.
3.
Marks M, Botta R, Abe R, Beachkofsky T, Boothman I, Carleton B, et al.
Front Med (Lausanne)
. 2023 Oct;
10:1213889.
PMID: 37901413
Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN) is a predominantly drug-induced disease, with a mortality rate of 15-20%, that engages the expertise of multiple disciplines: dermatology, allergy, immunology, clinical pharmacology, burn surgery,...
4.
Balagula Y, Ortega A, Fazal M, Pasieka H, Mattei P, Kuhn D, et al.
JAAD Int
. 2023 Jul;
12:160-161.
PMID: 37456621
No abstract available.
5.
Waters M, Dobry A, Le S, Shinkai K, Beachkofsky T, Davis M, et al.
JAMA Dermatol
. 2023 May;
159(7):772-777.
PMID: 37256599
Importance: Scoring systems for Stevens-Johnson syndrome and epidermal necrolysis (EN) only estimate patient prognosis and are weighted toward comorbidities and systemic features; morphologic terminology for EN lesions is inconsistent. Objectives:...
6.
Lehloenya R, Phillips E, Pasieka H, Peter J
Immunol Allergy Clin North Am
. 2022 Apr;
42(2):219-238.
PMID: 35469616
The imagery of pigmented skin is underrepresented in teaching materials such as textbooks, journals, and online references, and this has resulted in poorer diagnostic and management outcomes of skin pathology,...
7.
Rick J, Rrapi R, Chand S, Shinohara M, Strowd L, Pasieka H, et al.
J Am Acad Dermatol
. 2022 Feb;
86(5):985-992.
PMID: 35202773
Calciphylaxis is a rare and devastating condition with important systemic ramifications. This second-part of our CME aims to educate the practicing dermatologist on the current standard of care once a...
8.
Rick J, Strowd L, Pasieka H, Saardi K, Micheletti R, Zhao M, et al.
J Am Acad Dermatol
. 2022 Feb;
86(5):973-982.
PMID: 35114300
Calciphylaxis is an uncommon but devastating disorder characterized by vascular calcification and subsequent cutaneous tissue necrosis. This results in exquisitely painful and slow healing wounds that portend exceptionally high morbidity...
9.
Chang W, Abe R, Anderson P, Anderson W, Ardern-Jones M, Beachkofsky T, et al.
J Dermatol Sci
. 2021 Nov;
104(2):146-147.
PMID: 34763988
No abstract available.
10.
Kirloskar K, Dekker P, Kiene J, Zhou S, Bekeny J, Rogers A, et al.
Adv Wound Care (New Rochelle)
. 2021 Oct;
11(12):650-656.
PMID: 34714156
To evaluate the role of disease-modifying antirheumatic drugs (DMARDs) on wound healing outcomes of patients with autoimmune disease at our tertiary wound care center. Retrospective review of patients presenting to...